Tag: Hatch-Waxman Act
How Generic Drugs Saved $3.4 Trillion: The Real Impact on Healthcare Costs
Generic and biosimilar drugs saved the US healthcare system $467 billion in 2024. Learn how these low-cost alternatives work, the history of the Hatch-Waxman Act, and future projections for trillion-dollar savings.
Read more
Manufacturing of Authorized Generics: Who Actually Makes Them
Discover who manufactures authorized generics. Learn how brand-name companies like Pfizer use subsidiaries and contract makers to produce lower-cost versions of their own drugs under the Hatch-Waxman Act.
Read more
Generic Drug Market Entry: How Competitors Enter After the First Generic
Learn how the generic drug market works, from the first mover's 180-day exclusivity to the dramatic price crashes that happen when multiple competitors enter.
Read more
Tentative Approval and Patent Litigation: Your Guide to Generic Market Entry
Learn how tentative approval and patent litigation affect generic drug market entry. Discover the Hatch-Waxman Act's role and tips to avoid costly FDA delays.
Read more
When Do Drug Patents Expire? Understanding the 20-Year Term and Real-World Timelines
Drug patents last 20 years from filing, but most drugs have only 7-12 years of market exclusivity due to long approval times. Learn how patent extensions, regulatory exclusivity, and litigation delay generic entry - and what it means for drug prices.
Read more